| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.22 | 5e-06 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.83 | 0.0007 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.14 | 0.003 |